Loading…

Sarcoma of vulva, vagina and ovary

Less than 5% of vulvar, vaginal and ovarian malignant diseases are sarcomas. Adequate knowledge of these particular malignant diseases is essential for accurate diagnosis and for choice of surgical treatment, adjuvant therapy and efficient medical treatment in relapse. A crucial aspect in the manage...

Full description

Saved in:
Bibliographic Details
Published in:Best practice & research. Clinical obstetrics & gynaecology 2011-12, Vol.25 (6), p.797-801
Main Authors: Magné, Nicolas, MD, PhD, Pacaut, Cécile, MD, Auberdiac, Pierre, MD, Jacquin, Jean-Philippe, MD, Chargari, Cyrus, MD, PhD, Chauleur, Céline, MD, PhD, Haie Meder, Christine, MD, Merrouche, Yacine, MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Less than 5% of vulvar, vaginal and ovarian malignant diseases are sarcomas. Adequate knowledge of these particular malignant diseases is essential for accurate diagnosis and for choice of surgical treatment, adjuvant therapy and efficient medical treatment in relapse. A crucial aspect in the management of women with these diseases is a multidisciplinary approach. Globally, presenting signs and symptoms of these sarcomas are non-specific of histological type but linked to initial location. In view of this, management should be undertaken by clinicians experienced in these particular malignancies. Long-term side-effects, particularly in children with sarcoma, adversely affect quality of life. New treatment strategies require special attention.
ISSN:1521-6934
1532-1932
DOI:10.1016/j.bpobgyn.2011.07.001